You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Colorcon
Medtronic
Express Scripts
Harvard Business School

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Kynurenic Acid

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Kynurenic Acid?

Kynurenic Acid is an investigational drug.

There have been 4 clinical trials for Kynurenic Acid. The most recent clinical trial was a Phase 1 trial, which was initiated on February 16th 2018.

The most common disease conditions in clinical trials are Schizophrenia, Inflammation, and Chronic Pain. The leading clinical trial sponsors are University of Maryland, Hopital Lariboisière, and Fondation Apicil.

There are five hundred and ninety-one US patents protecting this investigational drug and four international patents.

Recent Clinical Trials for Kynurenic Acid
TitleSponsorPhase
The Effects of Kynurenine Aminotransferase Inhibition in People With SchizophreniaUniversity of MarylandPhase 1/Phase 2
Ketamine's Efficiency in the Treatment of Chronic Pain: Kynurenin PathwayFondation ApicilPhase 3
Ketamine's Efficiency in the Treatment of Chronic Pain: Kynurenin PathwayHopital LariboisièrePhase 3

See all Kynurenic Acid clinical trials

Clinical Trial Summary for Kynurenic Acid

Top disease conditions for Kynurenic Acid
Top clinical trial sponsors for Kynurenic Acid

See all Kynurenic Acid clinical trials

US Patents for Kynurenic Acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Kynurenic Acid   Start Trial Biomarkers for differentiating between non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD) METANOMICS HEALTH GMBH (Berlin, DE) UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN (Kiel, DE)   Start Trial
Kynurenic Acid   Start Trial Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps Universal Diagnostics, S. L. (Seville, ES)   Start Trial
Kynurenic Acid   Start Trial Amphiphilic compounds with neuroprotective properties USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (Praha, CZ) FYZIOLOGICKY USTAV AV CR, V.V.I. (Praha, CZ)   Start Trial
Kynurenic Acid   Start Trial Solution phase homogeneous assays Beckman Coulter, Inc. (Brea, CA)   Start Trial
Kynurenic Acid   Start Trial Pathway specific markers for diagnosing irritable bowel syndrome Nestec S.A. (Vevey, CH)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Kynurenic Acid

Drugname Country Document Number Estimated Expiration Related US Patent
Kynurenic Acid Australia 2011273748 2030-06-10   Start Trial
Kynurenic Acid Brazil 112012031232 2030-06-10   Start Trial
Kynurenic Acid Canada 2799032 2030-06-10   Start Trial
Kynurenic Acid European Patent Office 2580596 2030-06-10   Start Trial
Kynurenic Acid European Patent Office 2863227 2030-06-10   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Colorcon
Medtronic
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.